Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
14.70
-0.90 (-5.77%)
Jan 21, 2025, 4:00 PM EST - Market closed
Forte Biosciences Employees
Forte Biosciences had 9 employees as of December 31, 2023. The number of employees increased by 3 or 50.00% compared to the previous year.
Employees
9
Change (1Y)
3
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$3,799,444
Market Cap
93.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9 | 3 | 50.00% |
Dec 31, 2022 | 6 | 1 | 20.00% |
Dec 31, 2021 | 5 | -4 | -44.44% |
Dec 31, 2020 | 9 | 8 | 800.00% |
Dec 31, 2019 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
FBRX News
- 2 months ago - Forte Biosciences to Host R&D Day December 3, 2024 - Business Wire
- 2 months ago - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Business Wire
- 2 months ago - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update - Business Wire
- 5 months ago - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update - Business Wire
- 8 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 9 months ago - Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - Business Wire
- 11 months ago - Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update - Business Wire
- 1 year ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire